Role of Topical Heparin in Treatment of Burn at Tertiary Care Hospital in Western Rajasthan
Topical Heparin in Treatment of Burn
Background: Heparin is a multifaceted compound with uses not only as an anticoagulant, but also as an anti-inflammatory, anti-allergenic, anti-histaminic, anti-serotonin, anti-proteolytic and neoangiogenic agent. The aim of the study was to study the effect of topical heparin in the management of burns in terms of morbidity, mortality & safety. Subjects and Methods: A hospital based RCT with total duration of 16 months from June, 2018 to September, 2019 with 100 patients (age between 15-45 years, burns from 20-60%, with less than 48 hours duration), randomly enrolled into 2 groups, after initial resuscitative measures, 50 cases receiving Topical Heparin treatment, 50 controls receiving conventional treatment (1% silver sulphadiazine) with i.v. antibiotics, after explaining the study objectives and taking informed written consent. Data analysis was performed using Epi Info software. Results: Patients treated with topical heparin experienced statistically significant (p<0.05) improved pain relief, rapid healing, lesser complications and reduced duration of hospital stays. Conclusion: The current study demonstrates that topical heparin can improve clinical outcomes in the treatment of burn injury.
Saliba MJ. Heparin in the treatment of burns: a review. Burns. 2001;27(4):349–358. Available from: https://dx.doi.org/10.1016/s0305-4179(00)00130-3.
Rayes A, Astiazaran JA, Chavez CC, Jaramilla F, Saliba MJ. Burns treated with and without heparin: Controlled use in a thermal disaster. Ann Burns Fire Disasters. 2001;14:183–191.
Lu J, Xu T. Heparin for the Treatment of Burns. Intervent Prot Cochrane Coll. 2011;2:45–54.
Saliba MJ. The effects and uses of heparin in the care of burns that improves treatment and enhances the quality of life. Acta Chir Plast. 1997;39:13–19.
Tyrrell DJ, Horne AP, Holme KR, Preuss JM, Page CP. Heparin in infl ammation: potential therapeutic applications beyond anticoagulation. Adv Pharmacol. 1999;46:151–208.
Saliba MJ. Heparin in the treatment of burns: a review. Burns. 2001;27(4):349–58.
Elsayed E, Becker RC. The impact of heparin compounds on cellular inflammatory responses: A construct for future investigation and pharmaceutical development. J Thromb Thrombolysis. 2003;15:11–19.
Peplow PV. Glycosaminoglycan: a candidate to stimulate the repair of chronic wounds. Thrombosis Haemostasis. 2005;94(07):4–16. Available from: https://dx.doi.org/10.1160/th04-12-0812.
Wang J, Zheng H, Qiu X, Kulkarni A, Fink LM, Hauer-Jensen
M. Modulation of the intestinal response to ionizing radiation by anticoagulant and non-anticoagulant heparins. Thrombosis Haemostasis. 2005;94(11):1054–1059. Available from: https://dx.doi.org/10.1160/th05-05-0330.
Masoud M, Wani AH, Darzi MA. Topical heparin versus conventional treatment in acute burns: A comparative study. Indian J Burns. 2014;22(1):43–43. Available from: https://dx.doi.org/10.4103/0971-653x.147002.
Bharathi M, Sudhakar PV. Role of topical heparin therapy in thermal burns. Int J Cont Med Res. 2017;4(11):2235–2239.
Venakatachalapathy TS, Kumar M, Saliba S, J M. A comparative study of burns treated with topical heparin and without heparin. Ann Burns Fire Disasters. 2007;20(4):189– 198.
Zayas GJ, Bonilla AM, Saliba MJ. Heparin reduced mortality and sepsis in severely burned children. Ann Burns Fire Disasters. 2007;20(1):29–34.
Barretto MG, Mda C, Serra G, Afiune MC, Praxedes JB, Pagani HE, et al. Comparative study of conventional and topical heparin treatments for burns analgesia. Rev Assoc Med Bras. 2010;56(1):51–56.
Manzoor S, Khan FA, Muhammad S, Qayyum R, Muhammad I, Nazir U, et al. Comparative study of conventional and topical heparin treatment in second degree burn patients for burn analgesia and wound healing. Burns. 2019;45(2):379–386. Available from: https://dx.doi.org/10.1016/j.burns.2018.05.010.
Copyright (c) 2020 Author
This work is licensed under a Creative Commons Attribution 4.0 International License.